Lester Amends LifeStance Stake to 4.2% as of Dec 31, 2023
Ticker: LFST · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1845257
| Field | Detail |
|---|---|
| Company | Lifestance Health Group, Inc. (LFST) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, amendment, healthcare-services
TL;DR
**Insider Michael K. Lester now owns 4.2% of LifeStance Health Group.**
AI Summary
Michael K. Lester, a key individual associated with LifeStance Health Group, Inc., filed an amended SC 13G/A on January 24, 2024, reporting beneficial ownership of 15,953,887 shares of common stock, representing 4.2% of the company's outstanding shares as of December 31, 2023. This filing indicates a slight decrease in his reported percentage of ownership from a previous filing, which could signal a minor shift in his investment strategy or a dilution due to new share issuance. Investors should note this change as it reflects the updated stake of a significant insider.
Why It Matters
This filing updates the public on the ownership stake of a significant insider, Michael K. Lester, in LifeStance Health Group, Inc., which can influence investor sentiment and perceptions of company stability.
Risk Assessment
Risk Level: low — This filing is an update on an existing ownership stake and does not indicate any immediate high-risk events for the company.
Analyst Insight
Investors should monitor future SC 13G/A filings from Michael K. Lester for any significant changes in his ownership percentage, as large increases or decreases could signal his evolving confidence in LifeStance Health Group, Inc.'s future.
Key Numbers
- 15,953,887 — Shares Beneficially Owned (This is the total number of shares Michael K. Lester has sole voting and dispositive power over.)
- 4.2% — Percentage of Class (This represents Michael K. Lester's total ownership stake in LifeStance Health Group, Inc.)
- $0.01 — Par Value per Share (This is the nominal value assigned to each common stock share of LifeStance Health Group, Inc.)
Key Players & Entities
- Michael K. Lester (person) — Reporting Person, beneficial owner of LifeStance Health Group, Inc. shares
- LifeStance Health Group, Inc. (company) — Subject company whose shares are being reported
- 15,953,887 (dollar_amount) — Number of shares beneficially owned by Michael K. Lester
- 4.2% (dollar_amount) — Percentage of class represented by Michael K. Lester's ownership
- December 31, 2023 (date) — Date of event which requires filing of this statement
Forward-Looking Statements
- Michael K. Lester will maintain a significant, but non-controlling, stake in LifeStance Health Group, Inc. (Michael K. Lester) — medium confidence, target: December 31, 2024
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person in this SC 13G/A filing is Michael K. Lester, as stated in Item 1 of the Schedule 13G.
What is the total number of shares beneficially owned by Michael K. Lester as of December 31, 2023?
As of December 31, 2023, Michael K. Lester beneficially owned 15,953,887 shares, as reported in Row 9 of the Schedule 13G cover page.
What percentage of LifeStance Health Group, Inc.'s common stock does Michael K. Lester own?
Michael K. Lester owns 4.2% of the class of common stock of LifeStance Health Group, Inc., as indicated in Row 11 of the Schedule 13G cover page.
What is the CUSIP number for LifeStance Health Group, Inc.'s common stock?
The CUSIP number for LifeStance Health Group, Inc.'s common stock is 53228F101, as listed on the Schedule 13G.
What type of filing is this document, and what does the 'A' signify?
This document is an SC 13G/A filing. The 'A' signifies that it is an amendment to a previously filed Schedule 13G, as indicated in the form type and title 'Amendment No. 2'.
Filing Stats: 728 words · 3 min read · ~2 pages · Grade level 8.3 · Accepted 2024-01-24 16:30:26
Key Financial Figures
- $0.01 — me of Issuer) Common stock, par value $0.01 per share (Title of Class of Securiti
Filing Documents
- d122272dsc13ga.htm (SC 13G/A) — 32KB
- 0001193125-24-014263.txt ( ) — 33KB
From the Filing
SC 13G/A 1 d122272dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* LifeStance Health Group, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 53228F101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1. Names of Reporting Persons Michael K. Lester 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization United Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 15,953,887 6. Shared Voting Power 0 7. Sole Dispositive Power 15,953,887 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 15,953,887 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 4.2% (1) 12. Type of Reporting Person (See Instructions) IN 1 Calculated based on 378,607,491 shares of common stock, par value $0.01 per share, outstanding as of November 1, 2023 as reported on the Issuers 10-Q, filed on November 8, 2023. SCHEDULE 13G Item 1. (a) Name of Issuer LifeStance Health Group, Inc., Delaware corporation (the Issuer) (b) Address of Issuers Principal Executive Offices 4800 N. Scottsdale Road, Suite 2300, Scottsdale, Arizona 85251 Item 2. (a) Name of Person Filing This Schedule 13G is being filed on behalf of Michael K. Lester (b) Address of Principal Business Office or, if none, Residence The address of the principal business office of the Reporting Person is c/o LifeStance Health Group, Inc., 4800 N. Scottsdale Road, Suite 2300, Scottsdale, Arizona 85251. (c) Citizenship United States (d) Title of Class of Securities Common stock, par value $0.01 per share (the Common Stock) (e) CUSIP Number 53228F101 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: This Item 3 is not applicable. Item 4. (a) Amount beneficially owned: As of the date hereof, the Reporting Person beneficially owns 15,953,887 shares of Common Stock, representing approximately 4.2% of the outstanding shares of Common Stock. The percentage of the outstanding shares of Common Stock held by the Reporting Person is based on 378,607,491 shares of Common Stock issued and outstanding as of November 1, 2023 as reported on the Issuers 10-Q, filed on November 8, 2023. (b) Percent of class: See Item 4(a) hereof. (c) Number of shares as to which the person has: Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following . Item 6. None. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person This Item 7 is not applicable. Item 8. Identification and Classification of Members of the Group This Item 8 is not applicable. Item 9. Notice of Dissolution of Group This Item 9 is not applicable. Item 10. Certification This Item 10 is not applicable. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 24, 2024 By: /s/ Michael Lester Name: Michael Lester